K. Conklin

Integrative Cancer Therapies · 2004

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.

Whom K. Conklin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. W. Earnshaw

Who trusts K. Conklin overall

  1. E. Kurutaş
  2. Lucas B. Sullivan
  3. T. Ozben
  4. Patrik Poprac
  5. P. Sridevi

Papers from K. Conklin's perspective

Ordered by how strongly the researchers K. Conklin trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Induction of apoptosis by cancer chemotherapy. (Experimental Cell Research)
  2. THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL
  3. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. (Frontiers in Bioscience)
  4. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
  5. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. (Cancer Research)
  6. Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors (EMBO Molecular Medicine)
  7. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways (Nucleic Acids Research)
  8. Involvement of Poly(ADP-ribose) Polymerase-1 and XRCC1/DNA Ligase III in an Alternative Route for DNA Double-strand Breaks Rejoining* (Journal of Biological Chemistry)
  9. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. (Journal of Clinical Oncology)
  10. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer (British Journal of Cancer)

Their papers